Targeting CaMK4 in SLE
Targeting CaMK4 in SLE
批准号:
9247888
负责人:
George C Tsokos
金额:
$35.94万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2018-03-31
关键词:
AffectAmericanAntibodiesAutoimmune DiseasesAutoimmunityCD3 AntigensCa(2+)-Calmodulin Dependent Protein KinaseCalciumCell DeathCell NucleusCell ProliferationCell physiologyCellsClinicalCollaborationsCytoplasmDataDefectDevelopmentDisclosureDiseaseDrug Delivery SystemsEffector CellEtiologyFunctional disorderGenerationsGeneticHumanImmuneImmune responseImmune systemInterleukin-17Interleukin-2KidneyLupusLupus NephritisMolecularMusOrganPatientsPharmaceutical PreparationsPharmacologyPhosphotransferasesProductionProliferatingPublishingRegulationRegulatory T-LymphocyteResearchSystemSystemic Lupus ErythematosusT-LymphocyteTechnologyTissuesUniversitiesWomanWorkbasecytotoxicexperimental studyimmunoregulationinhibitor/antagonistinnovationlupus prone micemesangial cellnovelperipheral bloodpublic health relevanceresponsetargeted delivery
中文摘要
描述(由申请人提供):系统性红斑狼疮(SLE)是一种病因不明的自身免疫性疾病,以多种T细胞效应物功能障碍为特征。白细胞介素-2 (IL-2)的产生在SLE患者和狼疮易感小鼠中减少,这有助于疾病的免疫发病机制。这一建议是基于已发表的和初步的数据,这些数据表明SLE患者血清中存在的抗cd3 /TCR抗体导致钙/钙调蛋白激酶4 (CaMK4)从细胞质转移到细胞核,从而抑制IL-2的产生。在狼疮易发的MRL中。lpr狼疮易感小鼠,小药物抑制剂抑制或基因缺失CaMK4可抑制自身免疫、系膜细胞增殖和狼疮肾炎。在其他数据中,CaMK4似乎参与了调节性T细胞的产生。基于这些数据,我们假设丝氨酸/苏氨酸激酶CaMK4通过抑制IL-2的产生和Treg的功能来促进自身免疫的表达,并通过促进肾小球系膜细胞的增殖来促进狼疮肾炎的发展。首先,我们将确定CaMK4易位到SLE T细胞的细胞核,确定它如何被激活以及它如何影响免疫调节。其次,我们将确定在系膜细胞中表达的CaMK4是否独立负责过度增殖和狼疮性肾炎的发展。第三,我们计划使用装载CaMK4抑制剂并标记有抗体的纳米脂凝胶将药物输送到T细胞和系膜细胞。为了进行这项研究,我们将使用细胞
英文摘要
DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is an autoimmune disorder of unknown etiology characterized by diverse T cell effector dysfunction. Interleukin-2 (IL-2) production is decreased in patients with SLE and lupus-prone mice and this contributes to the immunopathogenesis of the disease. This proposal is based on published and preliminary data which demonstrate that anti-CD3/TCR antibodies present in the sera of patients with SLE cause translocation of Calcium/calmodulin kinase 4 (CaMK4) from the cytoplasm to the nucleus where it suppresses IL-2 production. In the lupus prone MRL.lpr lupus-prone mouse, pharmacologic inhibition or genetic deletion of CaMK4 with a small drug inhibitor suppresses autoimmunity, mesangial cell proliferation and lupus nephritis. In additional data, CaMK4 appears to be involved in the generation of regulatory T cells. Based on these data we hypothesize that the ser/thr kinase CaMK4 contributes to the expression of autoimmunity by suppressing IL-2 production and Treg function and to the development of lupus nephritis by promoting mesangial cell proliferation. First, we will establish that CaMK4 translocates to the nucleus of SLE T cells, determine how it becomes activated and how it affects immunoregulation. Second, we will establish whether CaMK4 expressed in mesangial cells is independently responsible for excessive proliferation and the development of lupus nephritis. And, third, we plan to use nanolipogels loaded with an inhibitor of CaMK4 and tagged with antibodies to deliver the drug to T and mesangial cells. To carry out the studies we will use cells
from patients with SLE and a newly constructed MRL.lpr mouse which lacks CaMK4 and nanolipogel technology to delver the CaMK4 inhibitor. The proposal identifies a new Ser/Thr kinase, CaMK4, in the regulation/dysregulation of the immune response and proliferation of mesangial cells and proposes the use of a novel nanolipogel delivery system to target a small drug inhibitor of CaMK4 to T and mesangial cells. The significance of the proposed work lies with the fact that it presents a novel target for the treatment of SLE and that it develops a targeted delivery of a small drug.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2019
期刊:
Transactions of the American Clinical and Climatological Association
影响因子:
--
作者:
[G. Tsokos;M. Tsokos]
通讯作者:
G. Tsokos;M. Tsokos
DOI:
10.3109/08916934.2014.915954
发表时间:
2014-11
期刊:
Autoimmunity
影响因子:
3.5
作者:
[Koga T, Mizui M, Yoshida N, Otomo K, Lieberman LA, Crispín JC, Tsokos GC]
通讯作者:
Tsokos GC
DOI:
10.3389/fimmu.2021.623844
发表时间:
2021
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Kono M, Yoshida N, Tsokos GC]
通讯作者:
Tsokos GC
DOI:
10.1002/art.39665
发表时间:
2016-08
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
[Koga T, Otomo K, Mizui M, Yoshida N, Umeda M, Ichinose K, Kawakami A, Tsokos GC]
通讯作者:
Tsokos GC
DOI:
10.1002/art.39499
发表时间:
2016-04
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
[Ichinose K, Ushigusa T, Nishino A, Nakashima Y, Suzuki T, Horai Y, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Arima K, Nakamura H, Obata Y, Yamamoto K, Origuchi T, Nishino T, Kawakami A, Tsokos GC]
通讯作者:
Tsokos GC
共 7 条
T cells in Lupus
-
批准号:10308697
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2019
-
负责人:George C Tsokos
-
依托单位:
T cells in Lupus
-
批准号:10533282
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2019
-
负责人:George C Tsokos
-
依托单位:
T cells in Lupus
-
批准号:10063477
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2019
-
负责人:George C Tsokos
-
依托单位:
Phosphatases in Systemic Autoimmunity
-
批准号:10468134
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2018
-
负责人:George C Tsokos
-
依托单位:
Phosphatases in Systemic Autoimmunity
-
批准号:10000837
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2018
-
负责人:George C Tsokos
-
依托单位:
Phosphatases in Systemic Autoimmunity
-
批准号:10242137
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2018
-
负责人:George C Tsokos
-
依托单位:
Targeting CaMK4 in SLE
-
批准号:8640886
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2013
-
负责人:George C Tsokos
-
依托单位:
Targeting CaMK4 in SLE
-
批准号:8480535
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2013
-
负责人:George C Tsokos
-
依托单位:
Targeting CaMK4 in SLE
-
批准号:9040093
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2013
-
负责人:George C Tsokos
-
依托单位:
Expanded double negative T cells in SLE
-
批准号:8453448
-
项目类别:
-
资助金额:$40.48万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
Expanded double negative T cells in SLE
-
批准号:8653524
-
项目类别:
-
资助金额:$43.07万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
Expanded double negative T cells in SLE
-
批准号:7791807
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
Expanded double negative T cells in SLE
-
批准号:8066298
-
项目类别:
-
资助金额:$43.07万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
Expanded Double Negative T cells in SLE.
-
批准号:10620721
-
项目类别:
-
资助金额:$50.48万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
Expanded Double Negative T cells in SLE.
-
批准号:10295607
-
项目类别:
-
资助金额:$52.36万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
Expanded double negative T cells in SLE
-
批准号:8259759
-
项目类别:
-
资助金额:$43.07万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
Expanded Double Negative T cells in SLE.
-
批准号:10424576
-
项目类别:
-
资助金额:$50.48万
-
财政年份:2010
-
负责人:George C Tsokos
-
依托单位:
CIS School in Systemic Autoimmune Diseases
-
批准号:7664206
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2009
-
负责人:George C Tsokos
-
依托单位:
CIS School in Systemic Autoimmune Diseases
-
批准号:7800479
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2009
-
负责人:George C Tsokos
-
依托单位:
CIS School in Systemic Autoimmune Diseases
-
批准号:7484755
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2008
-
负责人:George C Tsokos
-
依托单位:
海外基金